CardioDx

The developer has presented clinical results that provide a base for completing development of a multi-protein test kit and conducting a clinical trial in advance of FDA submission.  

The deal with Quest enables clinicians to order blood draws on patients through its facilities for testing with CardioDx's Corus CAD test.

The data, presented at the American College of Cardiology meeting, showed that doctors referred only 4 percent of women with low Corus CAD scores for further cardiac evaluation.

In an SEC document, the company called current market conditions for an IPO unattractive. 

CardioDx Raises $35M

The financing will go toward further commercialization of its Corus CAD test, as well as other genomics tests for coronary artery disease. 

NEW YORK (GenomeWeb) – Results of a single-center retrospective study focusing on a predominately African-American patient population have added to mounting evidence that Corus CAD, CardioDx's gene expression-based coronary artery disease rule-out test, can help clinicians avoid unnecessary refer

NEW YORK (GenomeWeb) — DxTerity Diagnostics has begun commercializing blood sample collection products and a multiplex PCR reagent kit.

NEW YORK (GenomeWeb) – Cardiovascular molecular diagnostics company CardioDx has raised $21 million toward a targeted goal of $25 million, it disclosed in a regulatory document filed on Wednesday.

NEW YORK (GenomeWeb) – CardioDx today announced that Aetna has established a clinical policy for the Corus CAD gene expression test for coronary artery disease.

Hologic this week disclosed that CFO Glenn Muir will be retiring on an unspecified date.

Pages

Researchers find that historical factors influence which genes are the most highly studied, the Atlantic reports.

The US National Science Foundation's new sexual harassment policy is to go into effect next month, according to Nature News.

Researchers report using genotyping to tie together illegal ivory shipments and trace them back to a handful of cartels, the New York Times reports.

In Nature this week: genomic ancestry analysis of Sardinians, current noncoding mutations in colorectal cancer, and more.